Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (4007)	9/27/1999 12:31:00 AM
From: DanZ	Read Replies (1) \| Respond to of 10293

The value of GUMM is not based solely on Zicam. In fact, I don't think that the stock discounts much value for Zicam at this point. Most of GUMM's value is due to prospects for nicotine gum, and you have failed to even acknowledge that it exists. You continue to use derogatory terms such as "quack medicine" to describe Zicam, but the link that you provided to explain your position doesn't even apply to the product. You need some more rationale because no unbiased person with half a brain would accept your opinion at face value. Anybody that thinks that their risk is zero in any stock should have their money in a bank CD. No matter what you think about a company, the risk is never zero and you are very foolish for saying this. Either you have very little experience or try to sweep your losses under the rug. Care to eat an AAPL? One last philosophical comment: Those who know more about a company will win over the long term. I simply know more about GumTech than you do and I know much more than I share with you. Howard E., Mike M., Street Walker, Bo Didley know more than you, among others. We are all long and there's a reason for it. <wink>